The Henry M. Jackson Foundation for the Advancement of Military Medicine; Inc.
发明人:
申请号：
EP16871218.0
公开号：
EP3384013A4
申请日:
2016.10.06
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Described herein are agents and methods for targeting antigen-specific B cells using engineered T cells, such as regulatory T cells or cytotoxic T cells, or bi-specific antibodies. The agents and methods can be used to reduce undesirable immune responses.
